Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06284447 · ClinicalTrials.gov registry record
Barriers to Cervical Cancer Screening
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 2,216
- Enrollment target
NCT06284447: Completed study, sponsored by Mayo Clinic.
NCT06284447 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 2,216 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06284447 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 2,216 participants
- Enrollment target
Study Summary
This study evaluates barriers to cervical cancer screening among non-compliant women.
Primary Outcome
Participants will receive a brief "Pap Smear Barriers Survey" (likely completed in 5-15 minutes) which asks yes/no/no preference questions regarding potential barriers to cervical cancer screening. Responses will be compared regionally and by Mayo Clinic Health System site.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,216 participants |
| Start Date | 2023-03-23 |
| Est. Completion | 2023-10-28 |
What the finished NCT06284447 record still lists
NCT06284447 is an observational study that tracks outcomes without assigning an intervention. Its 2,216 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06284447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06284447 about?
NCT06284447 is a clinical study titled "Barriers to Cervical Cancer Screening". This study evaluates barriers to cervical cancer screening among non-compliant women.
What is the current status of trial NCT06284447?
This trial is currently completed. The enrollment target is 2,216 participants. The study started on 2023-03-23. Estimated completion is 2023-10-28.
What interventions are being tested in trial NCT06284447?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06284447?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI